{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:09:19Z","timestamp":1759018159464,"version":"3.44.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jinf.2016.05.005","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T16:26:39Z","timestamp":1464971199000},"page":"174-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Re: Moxifloxacin should not be discounted in the treatment of bacterial meningitis"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0903-9046","authenticated-orcid":false,"given":"Fiona","family":"McGill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4573-449X","authenticated-orcid":false,"given":"Robert S.","family":"Heyderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jinf.2016.05.005_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jinf.2016.01.007","article-title":"The UK Joint specialist societies guideline on the management of community acquired bacterial meningitis in immunocompetent adults","volume":"72","author":"McGill","year":"2016","journal-title":"J Infect"},{"issue":"Suppl 3","key":"10.1016\/j.jinf.2016.05.005_bib2","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","article-title":"ESCMID guideline: diagnosis and treatment of acute bacterial meningitis","volume":"22","author":"van de Beek","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.jinf.2016.05.005_bib3","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/thoraxjnl-2015-207194","article-title":"Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial","volume":"70","author":"Brill","year":"2015","journal-title":"Thorax"},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2016.05.005_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000238642","article-title":"Ceftriaxone alone compared to ampicillin and chloramphenicol in the treatment of bacterial meningitis","volume":"34","author":"Girgis","year":"1988","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1016\/j.jinf.2016.05.005_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AAC.25.1.40","article-title":"Comparison of ceftriaxone and traditional therapy of bacterial meningitis","volume":"25","author":"Congeni","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"issue":"5876","key":"10.1016\/j.jinf.2016.05.005_bib6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/bmj.3.5876.379","article-title":"Trial of chloramphenicol for meningitis in northern savanna of Africa","volume":"3","author":"Whittle","year":"1973","journal-title":"Br Med J"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316300901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316300901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:23:15Z","timestamp":1759008195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445316300901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0163445316300901"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2016.05.005","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re: Moxifloxacin should not be discounted in the treatment of bacterial meningitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2016.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}